292 related articles for article (PubMed ID: 35337138)
1. Plant Terpenoids as Hit Compounds against Trypanosomiasis.
Durão R; Ramalhete C; Madureira AM; Mendes E; Duarte N
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337138
[TBL] [Abstract][Full Text] [Related]
2. Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence.
Pereira RM; Greco GMZ; Moreira AM; Chagas PF; Caldas IS; Gonçalves RV; Novaes RD
Parasitology; 2017 Sep; 144(10):1275-1287. PubMed ID: 28578742
[TBL] [Abstract][Full Text] [Related]
3. Conventional therapy and promising plant-derived compounds against trypanosomatid parasites.
Alviano DS; Barreto AL; Dias Fde A; Rodrigues Ide A; Rosa Mdo S; Alviano CS; Soares RM
Front Microbiol; 2012; 3():283. PubMed ID: 22888328
[TBL] [Abstract][Full Text] [Related]
4. Trypanocidal Essential Oils: A Review.
Morais MC; Souza JV; da Silva Maia Bezerra Filho C; Dolabella SS; Sousa DP
Molecules; 2020 Oct; 25(19):. PubMed ID: 33036315
[TBL] [Abstract][Full Text] [Related]
5. Advances in Drug Discovery against Neglected Tropical Diseases: Human African and American Trypanosomiasis.
Peerzada MN; Gaur A; Azam A
Curr Med Chem; 2021; 28(36):7544-7582. PubMed ID: 33949927
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Review of Chromane Analogues as Anti-protozoal Leads: A Decade's Worth of Evolution.
Jadhav SR; Karan Kumar B; Joshi RP; Suryakant CK; Chandu A; Muzaffar-Ur-Rehman M; Khetmalis YM; Nandikolla A; Murugesan S; Chandra Sekhar KVG
Curr Top Med Chem; 2023; 23(9):713-735. PubMed ID: 36786146
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru(II) Ferrocenyl Derivatives with Two Different Bioactive Ligands.
Rivas F; Del Mármol C; Scalese G; Pérez Díaz L; Machado I; Blacque O; Salazar F; Coitiño EL; Benítez D; Medeiros A; Comini M; Gambino D
Inorg Chem; 2024 Jun; ():. PubMed ID: 38860314
[TBL] [Abstract][Full Text] [Related]
9. The Production of
Özbilgin A; Çavuş İ; Nuraydın A; Özel Y
Turkiye Parazitol Derg; 2020 Mar; 44(1):7-11. PubMed ID: 32212582
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Strategies against
Santos ALS; Rodrigues IA; d'Avila-Levy CM; Sodré CL; Ritmeijer K; Branquinha MH
Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887779
[TBL] [Abstract][Full Text] [Related]
11. Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery.
Bhattacharya A; Corbeil A; do Monte-Neto RL; Fernandez-Prada C
Genes (Basel); 2020 Jun; 11(7):. PubMed ID: 32610603
[TBL] [Abstract][Full Text] [Related]
12. Diamidine activity against trypanosomes: the state of the art.
Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
[TBL] [Abstract][Full Text] [Related]
13. Update on relevant trypanosome peptidases: Validated targets and future challenges.
Alvarez VE; Iribarren PA; Niemirowicz GT; Cazzulo JJ
Biochim Biophys Acta Proteins Proteom; 2021 Feb; 1869(2):140577. PubMed ID: 33271348
[TBL] [Abstract][Full Text] [Related]
14. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
[TBL] [Abstract][Full Text] [Related]
15. Insight into Recent Drug Discoveries against Trypanosomatids and Plasmodium spp Parasites: New Metal-based Compounds.
Scarim CB; de Farias RL; Chiba DE; Chin CM
Curr Med Chem; 2022; 29(13):2334-2381. PubMed ID: 34533436
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
17. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
[TBL] [Abstract][Full Text] [Related]
18. Trypanocidal activity of marine natural products.
Jones AJ; Grkovic T; Sykes ML; Avery VM
Mar Drugs; 2013 Oct; 11(10):4058-82. PubMed ID: 24152565
[TBL] [Abstract][Full Text] [Related]
19. Recent Theoretical Studies Concerning Important Tropical Infections.
Scotti MT; Monteiro AFM; de Oliveira Viana J; Bezerra Mendonça Junior FJ; Ishiki HM; Tchouboun EN; De Araújo RSA; Scotti L
Curr Med Chem; 2020; 27(5):795-834. PubMed ID: 31296154
[TBL] [Abstract][Full Text] [Related]
20. Macromolecular Targets of Antiparasitic Germacranolide Sesquiterpenoids: An
Arnston PM; Setzer WN
Comb Chem High Throughput Screen; 2020; 23(6):477-503. PubMed ID: 32067612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
